Lifitegrast, as a novel therapeutic agent for dry eye disease (DED), has garnered considerable clinical attention, yet the prediction and risk …
Source: google.com
Lifitegrast, as a novel therapeutic agent for dry eye disease (DED), has garnered considerable clinical attention, yet the prediction and risk …
Source: google.com